CCR5 and neoplasm: Genetic reprogramming CAR T cells to express a CCR that increases tumor infiltration is one strategy that has been considered to enhance CAR homing, as other CCRs expressed by CAR T cells (e.g., CXCR3 or CCR5) do not presently complement the chemokine generated in the tumor [84].